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Infection with human herpesvirus type 8 and with human T-cell leukaemia virus type-1 shows strong geographic variations.
We conducted this study to assess prevalence and risk factors for human herpesvirus type 8 infection in Havana City, Cuba.
Information and residual serum samples already collected for a hospital based case–control study were used. A total of 379
individuals (267 males and 112 females; median age=63 years) were evaluated. Antibodies to the lytic antigen of human
herpesvirus type 8 were detected by using an immunoﬂuorescence assay, while human T-cell leukaemia virus type-1 serology
was performed by means of an ELISA test (alpha Biotech). Overall, 64 subjects (16.9%, 95% conﬁdence interval: 13.1–20.0)
were positive for human herpesvirus type 8 antibodies. Human herpesvirus type 8 seroprevalence signiﬁcantly increased with
age (odds ratio=1.9 for 565 vs 555 years), and was twice as frequent in blacks than in whites. No association emerged with
gender, socio-economic indicators, family size, history of sexually transmitted disease, sexual behaviour. Overall, 16 persons
had anti-human T-cell leukaemia virus type-1 antibodies (4.2%, 95% conﬁdence interval: 2.2–6.4). No relationship emerged
between human T-cell leukaemia virus type-1 and human herpesvirus type 8 serostatus. The study ﬁndings indicate that
human herpesvirus type 8 infection is relatively common in Havana City, Cuba, suggesting that Cuba may represent an
intermediate endemical area. Sexual transmission does not seem to play a major role in the spread human herpesvirus type 8
infection.
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Since its discovery in 1994, the human herpesvirus type 8 (HHV-
8) – the causal agent of Kaposi’s sarcoma (KS) – has been docu-
mented in virtually every form of KS, i.e., in the classic, or
Mediterranean type; in the endemic, or African type; and in the
AIDS-associated type (Chang et al, 1994; IARC Working Group
on the Evaluation of Carcinogenic Risks to Humans, 1997). Many
cross-sectional investigations conducted in different geographic
areas have put in evidence that the prevalence of HHV-8 infection
mirrors incidence rates of AIDS-unrelated KS. The lack of standar-
dised serological assays against HHV-8 antigens still represents a
major drawback for the comparison of ﬁndings from different
investigations (IARC Working Group on the Evaluation of Carci-
nogenic Risks to Humans, 1997; Schatz et al, 2001).
The prevalence of HHV-8 infection in Caribbean populations
has been little investigated, and, in these areas, incidence rates
for KS are not available (Lennette et al, 1996; Chatlynne and Abla-
shi, 1999). About 8% of male blood donors, aged 50 years or older,
were seropositive for HHV-8 infection in Jamaica (Manns et al,
1998), while an investigation conducted among Haitian women
migrated to the United States showed that 29% of them were
infected with HHV-8 (Goedert et al, 1997).
To study the distribution of HHV-8 infection, we took advan-
tage of a case–control study on oral cancer conducted in
Havana City, Cuba, part of a wider study coordinated by the Inter-
national Agency for Research on Cancer, Lyon (Garrote et al,
2001). In addition we examined the prevalence of seropositivity
for HHV-8 antibodies and certain potential correlates of infection,
such as socio-demographic characteristics, history of sexually trans-
mitted diseases (STD) and sexual behaviour, and infection with
human T-cell leukaemia virus type-1 (HTLV-1).
METHODS
This seroepidemiological investigation took advantage of residual
serum samples and from information already collected in a hospi-
tal-based case–control study (Garrote et al, 2001). The ﬁrst 200
patients newly diagnosed with cancer of the oral cavity or of the
oropharynx diagnosed between April 1996 and July 1999 in the
Instituto Nacional de Oncologı ￿a y Radiobiologı ￿a, Havana City,
Cuba, represented the cases of the original study. These 200 cases
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www.bjcancer.comlocal or systemic cancer treatment. During the same period, an
equal number of controls were identiﬁed from the same hospitals
of the cases and they were matched to cases by sex and age (in
quinquennia). The controls had no history of, or current suspicion
of, cancer of the oral cavity or oropharynx. With respect to eligible
reasons of hospital admission for control subjects, diseases asso-
ciated positively or negatively with the known or suspected risk
factors for cancer of the oral cavity or oropharynx (e.g., heavy
smoking or alcohol abuse) were excluded. Cases and controls
consented to participate voluntarily in the study and they were
in physical and mental conditions to give reliable answers to the
questionnaire (Garrote et al, 2001).
Potential infection with human immunodeﬁciency virus (HIV)
was investigated, though none of the enrolled individuals were
aware of having acquired HIV infection. However, neither the cases
nor the controls were tested for HIV antibodies.
Residual sera for assessing the presence of antibodies against
HHV-8 were not available for nine cases and 12 controls (median
age: 62 years) out of the 400 individuals originally enrolled in the
case–control study. Thus, 379 individuals (267 males and 112
females; median age=63 years) constituted the study group for
the present investigation.
Antibodies to the lytic antigen of HHV-8 were detected by using
an immunoﬂuorescence assay (IFA) based on BCBL-1 (body cavity
B-cell lymphomas) cell line (obtained through the AIDS Research
and Reference Reagent Program, Division of AIDS, National Insti-
tutes of Health, from Drs M McGrath and D Ganem) and on BCP-
1 cell line. For the purpose of this study, titres of 1:20 or more
were considered positive. Details on the assay were previously
published (Andreoni et al, 1999; Rezza et al, 1999; Schatz et al,
2001). HTLV-1 serology was performed by means of an ELISA test
(alpha Biotech). ELISA-positive ﬁndings were all conﬁrmed by
means of Western blot technique (GeneLab).
Statistical analysis
At univariate analysis, the chi-square test for trend was used to test
the statistical signiﬁcance between ordered categorical variables and
HHV-8 seropositivity (Armitage and Berry, 1987). Odds ratios
(OR) and their 95% conﬁdence intervals (CI) were used to assess
the association between HHV-8 seropositivity and various charac-
teristics and exposures by means of unconditional multiple logistic
regression (Breslow and Day, 1980).
RESULTS
Overall, 64 individuals (47 men and 17 women, median age=63
years) (16.9%, 95% CI: 13.1–20.0) were positive for HHV-8 anti-
bodies. Prevalence of HHV-8 infection was similar among the 191
patients with cancer (17.3%) and the 188 controls (16.5%)
(P=0.95) (data not shown in tables).
As listed in Table 1, HHV-8 seroprevalence signiﬁcantly
increased with the increase of age (w
2 for trend, P=0.04), ranging
from 12.2% in subjects younger than 55 years to 21.1% in those
aged 65 years or older (OR=1.9). HHV-8 infection was twice as
frequent in blacks than in whites (95% CI: 1.0–4.4), whereas males
and females presented similar seropositivity rates (17.6 and 15.2%,
respectively) (Table 1).
All associations described below were evaluated after adjustment
for age, gender, and ethnic group. None of the socio-economic
indicators (e.g., education: 45 years vs 59, OR=1.4, 95% CI:
0.7–3.0), and family size indicators (i.e., 58 siblings vs 43,
OR=1.4, 95% CI=0.7–2.9) turned out to be associated with
HHV-8 seropositivity (Table 1).
Seropositivity for HHV-8 antibodies was not associated with
history of STD, neither with sexual behaviour, such as age at ﬁrst
intercourse or lifetime number of sexual partners (Table 2). These
results did not change when the analysis was separately conducted
among males or females (data not shown in tables).
Overall, 16 of these 379 examined persons had anti-HTLV-1
antibodies (4.2%, 95% CI: 2.2–6.4). No relationship emerged
between HTLV-1 and HHV-8 serostatus, though a non-statistically
signiﬁcant inverse association was recorded (Table 2).
DISCUSSION
The prevalence of HHV-8 infection in this group of population
living in Havana City, Cuba, appeared to be intermediate between
those reported in areas where KS is rare, like northern Europe and
North America, and areas where KS is more common, like south-
ern Italy (Geddes et al, 1995; Parkin et al, 1997). Interestingly, the
ﬁndings of this seroprevalence investigation suggest that sexual
habits, particularly sexual promiscuity, are not among the main
determinants of HHV-8 infection in Cuba. The lack of association
between HHV-8 and HTLV-1 infections also points to a minor role
of the sexual route of transmission for these two viral infections in
the general population of Cuba.
Age and ethnic group turned out to be the strongest determi-
nants of HHV-8 infection. An increase in prevalence of HHV-8
infection with ageing has been consistently reported (IARC Work-

















(n=64) % (95% CI)
Age (years)
555 (n=98) 12.2 1
55–64 (n=101) 13.9 1.1 (0.5–2.4)
565 (n=180) 21.1 1.9 (0.9–3.9)
w
2 for trend 4.11; P=0.04
Gender
Males (n=267) 17.6 1
Females (n=112) 15.2 0.9 (0.5–1.6)
Ethnic group
b
White (n=285) 15.1 1
Black (n=46) 26.1 2.1 (1.0–4.4)
Mulatto (n=47) 19.2 1.4 (0.6–3.2)
Occupation
b
White collar (n=131) 14.5 1
Blue collar (n=119) 17.7 1.2 (0.6–2.4)
Farmers (n=52) 21.2 1.3 (0.6–3.1)
Housewives/other (n=60) 16.7 1.3 (0.5–3.2)
Education (years)
b
59( n=173) 13.9 1
6–8(n=101) 16.8 1.1 (0.5–2.2)
5=5 (n=80) 22.5 1.4 (0.7–3.0)
w
2 for trend 0.89; P=0.35
Spouse’s education (years)
59( n=170) 14.7 1
6–8(n=96) 18.8 1.1 (0.5–2.2)
5=5 (n=77) 16.9 0.9 (0.4–2.0)
w
2 for trend 0.02; P=0.89
Number of siblings
b
5=3 (n=113) 14.2 1
4–7(n=143) 16.8 1.2 (0.6–2.4)
58( n=123) 19.5 1.4 (0.7–2.9)
w
2 for trend 1.02; P=0.31
Total (n=379) 16.9
aMultiple logistic regression (MLR) odds ratio (OR) and 95% conﬁdence intervals (CI)
adjusted for gender, age and ethnic group.
bIn some items, the sum does not add up
to the total because of missing values.
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groups of the same age (i.e., with a median age of 63 years), the
HHV-8 prevalence recorded in this Cuban population appears to
be higher than that observed in Asian countries (IARC Working
Group on the Evaluation of Carcinogenic Risks to Humans,
1997; Chatlynne and Ablashi, 1999), and similar to that observed
among cancer patients aged 50 years or older in the South of Italy
(i.e., 16.0%) (Serraino et al, 2000; Vitale et al, 2001).
Black ethnic origin was associated with a two-fold higher risk of
being infected with HHV-8 than white origin, whereas mulatto
ethnic origin was at intermediate risk (i.e., 1.4-fold). Such observa-
tion mirrors ﬁndings from studies of other g-herpesviruses
conducted in North America, showing higher prevalence of antibo-
dies against Epstein-Barr virus (EBV) in black, as compared to
white Americans (Hallee et al, 1974), though explanations for these
ﬁndings are still unknown.
No association emerged, in this study, between HHV-8 and
demographic indicators, such as occupation and education,
suggesting that the spread of HHV-8 in the general population
of Havana City, Cuba, is not inﬂuenced by socio-economic differ-
ences. In this connection the lack of association between HHV-8
seropositivity and family size may be noted. None of the sexual
behaviours investigated, and none of the self-reported STD were
associated with HHV-8 infection. In accordance to other studies,
these ﬁndings tend to exclude a major role of sexual transmission
of HHV-8 in HIV-negative heterosexual adults (IARC Working
Group on the Evaluation of Carcinogenic Risks to Humans, 1997).
Sixteen out of the 379 study subjects (4.2%) were positive for
HTLV-1 antibodies. Such prevalence was slightly lower than those
observed in other Caribbean islands where HTLV-1 antibodies are
usually recognised in up to 15% of adults (Blattner et al, 1982;
Yoshida, 1999). Low prevalence for, or even lack of infection with
HTLV-I was found in other studies conducted on blood donors in
Cuba, some of which did not apparently discriminate between
HTLV-1 and HTLV-II (Hernandez Ramirez et al, 1991; Silva
Cabrera et al, 1997). However, the report of sporadic cases of
HTLV-1-associated with tropical spastic paraparesis suggests that
both the spread of HTLV-1 and major route of transmission in
Cuba need to be better investigated (Estrada et al, 1995). The lack
of association found in this investigation between HHV-8 and
HTLV-1 infections suggests that these viruses do not share similar
transmission modalities. This fact is little surprising since, in ende-
mic areas, HTLV-1 is mainly transmitted from mother to child by
breast feeding, or through infection via contaminated blood (IARC
Working Group on the Evaluation of Carcinogenic Risks to
Humans, 1996).
In conclusion, the overall ﬁndings show that HHV-8 infection is
relatively common among older adults living in Havana City,
Cuba, suggesting that Cuba represents an intermediate endemical
area. HHV-8 and HTLV-1 infections are likely to spread with
different routes, and sexual transmission does not seem to play a
major role in the spread of HHV-8 infection in Cuba.
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Table 2 Seropositivity for HHV-8 according to history of selected sexu-
ally transmitted diseases and sexual lifestyles. Cuba, 1996–1999
HHV-8-positive MLR-OR
a
(n=64) % (95% CI)
Sexual habits
Age at ﬁrst intercourse
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16–18 (n=97) 15.5 0.6 (0.3–1.4)
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w
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Lifetime number of sexual partners
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2–5(n=60) 18.3 1.2 (0.5–3.2)
6–10(n=49) 14.3 0.9 (0.2–2.7)
511 (n=100) 14.0 0.9 (0.2–2.3)
w
2 for trend 0.48; P=0.49
History of sexually transmitted diseases
Herpes genitalis
No (n=369) 16.8 1
Yes (n=10) 20.0 1.5 (0.3–7.6)
Gonorrhoea
No (n=336) 16.1 1
Yes (n=43) 23.3 1.4 (0.6–3.0)
Syphilis
No (n=371) 17.0 1
Yes (n=8) 12.5 0.5 (0.1–4.6)
HTLV-1
No (n=363) 17.4 1
Yes (n=16) 6.3 0.4 (0.0–3.0)
aMultiple logistic regression (MLR) odds ratios (OR) and 95% conﬁdence intervals
(CI) adjusted for gender, age and ethnic group. HTLV-1=human T-cell leukemia
virus type-1.
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